.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
Argus Health
Teva
Harvard Business School
Deloitte
Chinese Patent Office
McKinsey
Baxter

Generated: December 17, 2017

DrugPatentWatch Database Preview

NASACORT ALLERGY 24 HOUR Drug Profile

« Back to Dashboard

Which patents cover Nasacort Allergy 24 Hour, and when can generic versions of Nasacort Allergy 24 Hour launch?

Nasacort Allergy 24 Hour is a drug marketed by Sanofi Aventis Us and is included in one NDA. There are three patents protecting this drug.

This drug has thirty-eight patent family members in twenty-seven countries.

The generic ingredient in NASACORT ALLERGY 24 HOUR is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Drug patent expirations by year for NASACORT ALLERGY 24 HOUR

Pharmacology for NASACORT ALLERGY 24 HOUR

Medical Subject Heading (MeSH) Categories for NASACORT ALLERGY 24 HOUR

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis UsNASACORT ALLERGY 24 HOURtriamcinolone acetonideSPRAY, METERED;NASAL020468-002Oct 11, 2013OTCYesYes► Subscribe► SubscribeY► Subscribe
Sanofi Aventis UsNASACORT ALLERGY 24 HOURtriamcinolone acetonideSPRAY, METERED;NASAL020468-002Oct 11, 2013OTCYesYes► Subscribe► SubscribeY► Subscribe
Sanofi Aventis UsNASACORT ALLERGY 24 HOURtriamcinolone acetonideSPRAY, METERED;NASAL020468-002Oct 11, 2013OTCYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: NASACORT ALLERGY 24 HOUR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsNASACORT ALLERGY 24 HOURtriamcinolone acetonideSPRAY, METERED;NASAL020468-002Oct 11, 2013► Subscribe► Subscribe
Sanofi Aventis UsNASACORT ALLERGY 24 HOURtriamcinolone acetonideSPRAY, METERED;NASAL020468-002Oct 11, 2013► Subscribe► Subscribe
Sanofi Aventis UsNASACORT ALLERGY 24 HOURtriamcinolone acetonideSPRAY, METERED;NASAL020468-002Oct 11, 2013► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: NASACORT ALLERGY 24 HOUR

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,375,984 Aqueous-based pharmaceutical composition► Subscribe
7,122,206Aqueous-based pharmaceutical composition► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: NASACORT ALLERGY 24 HOUR

Country Document Number Estimated Expiration
Australia3647197► Subscribe
Canada2268927► Subscribe
China1235568► Subscribe
Hong Kong1022652► Subscribe
Brazil9710115► Subscribe
African Regional IP Organization (ARIPO)9901495► Subscribe
European Patent Office1382330► Subscribe
Australia737506► Subscribe
Eurasian Patent Organization001406► Subscribe
Norway318241► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Fuji
Chubb
McKinsey
Cipla
Mallinckrodt
Cantor Fitzgerald
Daiichi Sankyo
Teva
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot